Company

Endeavor EU

Research Services The Unmet Clinical Need of an Accurate Risk Stratification Method for Early Esophageal Adenocarcinoma in Barrett’s Esophagus Patients. Find Out More at Www.endeavoreu.com 31 employees

Employees: 31

endeavoreu.com LinkedIn

Endeavor EU Overview

Headquarters: The Unmet Clinical Need of an Accurate Risk Stratification Method for Early Esophageal Adenocarcinoma in Barrett’s Esophagus Patients. Find Out More at Www.endeavoreu.com
Website: endeavoreu.com
Industry: Research Services
Employees: 31
Founded: 2024
NAICS: Scientific Research and Development Services

Research and Development in the Physical, Engineering, and Life Sciences

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

Keywords

Striving to improve the quality of life of Barrett's esophagus patients

About Endeavor EU

ENDEAVOR is a 5-year research project funded by the European Union’s HORIZON research and innovation programme (HORIZON-MISS-2023-CANCER-01)*. With the expertise of 15 academic partners, 2 general hospitals and 2 industrial partners, the ENDEAVOR consortium strives to address the unmet clinical need of an accurate risk stratification method for early esophageal adenocarcinoma in Barrett’s Esophagus patients. Find out more at www.endeavoreu.com * Funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or the Health and Digital Executive Agency. Neither the European Union nor the granting authority can be held responsible for them.